Mingzhao Xing

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Transcription Factor

Papillary Thyroid

Metastatic Colorectal Cancer

Top Venues

The Journal of clinical endocrinology and metabolism

Journal of the National Cancer Institute

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Zhang, Shuhuang Lin, Zhuo Wang, Wenyong Zhang, Mingzhao Xing
Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targets in Thyroid Cancer. The Journal of clinical endocrinology and metabolism (2024)
Xiaopei Shen, Jie Tan, Rengyun Liu, Guangwu Zhu, Lisa Rooper, Mingzhao Xing
The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K-AKT pathway. Molecular oncology (2024)
Rengyun Liu, Guangwu Zhu, Jie Tan, Xiaopei Shen, Mingzhao Xing
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness. Journal of the National Cancer Institute 116 (5) (2024)
Rengyun Liu, Guangwu Zhu, Jie Tan, Xiaopei Shen, Mingzhao Xing
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness. Journal of the National Cancer Institute 116 (5) (2024)
Rengyun Liu, Guangwu Zhu, Jie Tan, Xiaopei Shen, Mingzhao Xing
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness. Journal of the National Cancer Institute 116 (5) (2024)
Rengyun Liu, Guangwu Zhu, Jie Tan, Xiaopei Shen, Mingzhao Xing
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness. Journal of the National Cancer Institute 116 (5) (2024)
Yuqing Zhang, Xiaoxin Zhang, Lifan Lin, Mingzhao Xing
Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer: a meta-analysis. The Journal of clinical endocrinology and metabolism (2024)
Shuhuang Lin, Zhuo Wang, Mingzhao Xing
Association between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality. The Journal of clinical endocrinology and metabolism (2023)
Qi Yang, Hui Dang, Jiaxin Liu, Xingye Wang, Jingyuan Wang, Xinhui Lan, Meiju Ji, Mingzhao Xing, Peng Hou
Hypoxia switches TET1 from being tumor-suppressive to oncogenic. Oncogene (2023)
Mingzhao Xing
Response to Letter to the Editor From Boucai et al: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer". The Journal of clinical endocrinology and metabolism 107 (7) (2022)
Huixiong Xu, Yifeng Zhang, Hongxun Wu, Ning Zhou, Xing Li, John P Pineda, Yun Zhu, Huijun Fu, Ming Ying, Shufang Yang, Jiandong Bao, Lulu Yang, Bingjie Zhang, Lehang Guo, Liping Sun, Feng Lu, Hanxiang Wang, Ying Huang, Tiantong Zhu, Xiaonan Wang, Qing Wei, Chunjun Sheng, Shen Qu, Zhongwei Lv, Dong Xu, Qian Li, Yongling Dong, Jianwu Qin, Tong Cheng, Mingzhao Xing
High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid Nodules. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Yubing Tao, Fei Wang, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo, Barbara Jarzab, Agnieszka Czarniecka, Alfred K Lam, Caterina Mian, Federica Vianello, Linwah Yip, Garcilaso Riesco-Eizaguirre, Pilar Santisteban, Christine J O'Neill, Mark S Sywak, Roderick Clifton-Bligh, Bela Bendlova, Vlasta Sýkorová, Shihua Zhao, Yangang Wang, Mingzhao Xing
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer. The Journal of clinical endocrinology and metabolism 106 (11) (2021)
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing
Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2. Proceedings of the National Academy of Sciences of the United States of America 118 (11) (2021)
Jie Tan, Rengyun Liu, Guangwu Zhu, Christopher B Umbricht, Mingzhao Xing
TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel. Proceedings of the National Academy of Sciences of the United States of America 117 (27) (2020)